or Try an Advanced Search...

    Ocular Hypertension Stocks List

    Symbol Grade Name % Change
    BLCO F Bausch + Lomb Corporation 0.00
    ABBV C AbbVie Inc. -1.28
    OCUL C Ocular Therapeutix, Inc. 0.15
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Instruments & Supplies
    Related Stock Lists: Cataract Surgery Cataracts Glaucoma Treatment Of Glaucoma Adalimumab Advanced Prostate Cancer Allergic Conjunctivitis Allergology Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Clinical Trial Combination Drugs Conjunctivitis Constipation Contact Lenses Cornea Crohn's Disease

    Related ETFs - A few ETFs which own one or more of the above listed Ocular Hypertension stocks.

    Symbol Grade Name Weight
    MEDI D Harbor Health Care ETF 10.38
    BOTZ C Global X Robotics & Artificial Intelligence Thematic ETF 10.01
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    GRID C First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 8.31
    FDL B First Trust Morningstar ETF 8.12
    View all Ocular Hypertension ETFs...
    Compare ETFs
    Compare BOTZ to GRID Compare MEDI to FDL Compare MEDI to GRID

        Ocular Hypertension Stocks Recent News

        Date Stock Title
        Jul 3 ABBV AbbVie Q2 IPR&D expenses to lower EPS by $0.52
        Jul 3 ABBV Company News for Jul 3, 2024
        Jul 3 ABBV AbbVie: A Hold Again (Rating Downgrade)
        Jul 2 ABBV With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
        Jul 2 ABBV AbbVie to Host Second-Quarter 2024 Earnings Conference Call
        Jul 1 ABBV 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
        Jul 1 ABBV AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
        Jul 1 ABBV AbbVie names Robert A. Michael to CEO role
        Jul 1 ABBV Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
        Jul 1 ABBV 3 Magnificent Stocks Retirees Can Buy and Hold Forever
        Jul 1 ABBV 10 clinical trials to watch in the second half of 2024
        Jun 29 ABBV How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
        Jun 28 ABBV How Medicare drug price negotiations could hit pharma stocks
        Jun 28 ABBV Coherus offloads Humira biosimilar Yusimry for $40m
        Jun 28 ABBV AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
        Jun 28 ABBV AbbVie, Genmab blood cancer therapy endorsed in EU
        Jun 28 ABBV Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
        Jun 28 ABBV AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
        Jun 28 ABBV AbbVie completes acquisition of Celsius Therapeutics for $250m
        Jun 28 ABBV AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Instruments & Supplies
        Related Stock Lists: Cataract Surgery Cataracts Glaucoma Treatment Of Glaucoma Adalimumab Advanced Prostate Cancer Allergic Conjunctivitis Allergology Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Clinical Trial Combination Drugs Conjunctivitis Constipation Contact Lenses Cornea Crohn's Disease
        Ocular Hypertension

        Browse All Tags